Data / Form D filings / Celator Pharmaceuticals Inc
Celator Pharmaceuticals Inc: Form D filings
Celator Pharmaceuticals Inc, a pharmaceuticals company in Princeton, NJ, filed 5 Form D notices with the SEC between 2010 and 2013. The latest, on May 13, 2013, reports $39.3 million sold of a $39.3 million offering to 306 investors.
Find out what Celator Pharmaceuticals Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 303B COLLEGE ROAD EAST, Princeton, NJ, 08540
- Phone
- (609) 243-0123
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1327467
The full lists. Form D filings in New Jersey: 714 rows, $35.70, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 13, 2013 | Amendment | $39,262,788 | $39,262,788 | $0 | 306 | Aug 28, 2012 | sec.gov |
| Aug 30, 2012 | New notice | $35,000,000 | $4,148,617 | $30,851,383 | 106 | Aug 28, 2012 | sec.gov |
| Dec 28, 2011 | New notice | $5,000,500 | $2,576,867 | $2,423,633 | 10 | Dec 15, 2011 | sec.gov |
| Sep 7, 2010 | New notice | $20,000,003 | $15,000,001 | $5,000,002 | 12 | Aug 25, 2010 | sec.gov |
| May 10, 2010 | New notice | $2,500,000 | $2,500,000 | $0 | 9 | May 3, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Lawrence T. Mayer | Executive Officer | |
| Scott S. Morenstein | Director | |
| Richard S. Kollender | Director | |
| Fred M. Powell | Executive Officer | |
| Joseph A. Mollica | Director | |
| Alex S. Zisson | Director | |
| Nicole S. Vitullo | Director | |
| Jackson T. Scott | Executive Officer, Director | |
| Kenneth A. Galbraith | Director |
Other pharmaceuticals companies in New Jersey that filed recently
- Grace Therapeutics, Inc. $10 million · Aug 11, 2026
Every Form D from the week of May 13, 2013 · All recent filings in New Jersey · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Celator Pharmaceuticals Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.